CLOCORTOLONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Clocortolone, and when can generic versions of Clocortolone launch?
Clocortolone is a drug marketed by Taro and is included in one NDA.
The generic ingredient in CLOCORTOLONE is clocortolone pivalate. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the clocortolone pivalate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Clocortolone
A generic version of CLOCORTOLONE was approved as clocortolone pivalate by TARO on April 21st, 2020.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CLOCORTOLONE?
- What are the global sales for CLOCORTOLONE?
- What is Average Wholesale Price for CLOCORTOLONE?
Summary for CLOCORTOLONE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for CLOCORTOLONE |
| DailyMed Link: | CLOCORTOLONE at DailyMed |
US Patents and Regulatory Information for CLOCORTOLONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro | CLOCORTOLONE PIVALATE | clocortolone pivalate | CREAM;TOPICAL | 206370-001 | Apr 21, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
